(Q37743536)

22 August 2017

1 reference

title

Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer (English)

1 reference

22 August 2017

0 references

0 references

Susanna Lintula

1

1 reference

22 August 2017

Kristina Hotakainen

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

Expert Opinion on Biological Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

1169-1180

1 reference

22 August 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Cancer patient survival--patterns, comparisons, trends--a population-based Cancer Registry study in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Non-invasive urothelial neoplasms: according to the most recent WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Urothelial tumorigenesis: a tale of divergent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

The treated natural history of high risk superficial bladder cancer: 15-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Photodynamic diagnosis in urology: state-of-the-art

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

The accuracy of urinary cytology in daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

The role of exfoliative cytology in the management of bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Carcinoma in situ of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Gender- and smoking-related bladder cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Urothelial cancer and some industry-related chemicals: an evaluation of the epidemiologic literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Bladder cancer following administration of cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Nitrate in drinking water and risk of death from bladder cancer: an ecological case-control study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Nitrate intake does not influence bladder cancer risk: the Netherlands cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Superficial bladder tumor. Aspects of clinical progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Dipstick haematuria and bladder cancer in men over 60: results of a community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Identification of a nuclear protein matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

A side by side comparison of cytology and biomarkers for bladder cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Prognostic utility of human complement factor H related protein test (the BTA stat Test).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Telomeres shorten during ageing of human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Structure and function of telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Life and cancer without telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

DD23 Biomarker: a prospective clinical assessment in routine urinary cytology specimens from patients being monitored for TCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Flow cytometric DNA/cytokeratin analysis of bladder lavage: methodical aspects and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Quantitative flow-microfluorometric analysis of the DNA in cells from neoplasms of the urinary bladder: correlation of aneuploidy with histological grading and the cytological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Image analysis combined with visual cytology in the early detection of recurrent bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Cigarette smoking and p53 mutations in lung cancer and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Urine cytology. It is still the gold standard for screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Applications of array technology: identification of molecular targets in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Identifying distinct classes of bladder carcinoma using microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Detection of messenger RNA for the beta-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Superficial and metachronous invasive bladder carcinomas are clonally related

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

Qualitative and Quantitative Detection of Urinary Human Complement Factor H-Related Protein (BTA stat and BTA TRAK) and Fragments of Cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as Markers for Transitional Cell Carcinoma of the Bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

A family of angiogenic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.489546

10.1517/14712598.2010.489546

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference